#1 Clinical Trials Search in Europe

Nomegestrol Acetate

Nomegestrol Acetate is a progestin hormone being studied in clinical trials for use in contraceptives and other women’s health applications. This article summarizes key findings from recent trials investigating Nomegestrol Acetate combined with estradiol in various formulations like oral pills and vaginal rings. The research aims to develop new birth control options with improved efficacy, safety profiles, and benefits for issues like dysmenorrhea.

Table of Contents

What is Nomegestrol Acetate?

Nomegestrol acetate (NOMAC) is a type of medication that belongs to the class of drugs called progestins. It is often used in combination with another hormone called estradiol (E2) for various medical purposes[1]. This combination is sometimes referred to as NOMAC-E2 in medical literature.

Nomegestrol acetate is also known by its brand name Zoely[2]. It’s important to note that this medication is often used in combination with estradiol, which is a form of estrogen naturally produced by the body.

Uses and Conditions Treated

Nomegestrol acetate is primarily used for the following purposes:

  • Contraception: It is used as a birth control method to prevent pregnancy[3].
  • Endometrial Polyps: It may be used in the treatment of endometrial polyps, which are growths attached to the inner wall of the uterus[4].
  • Endometrial Diseases: It can be used to treat various conditions affecting the lining of the uterus[4].
  • Multiple Sclerosis: Research is being conducted on its potential use in preventing relapses in multiple sclerosis patients after childbirth[5].
  • Dysmenorrhea: Studies are investigating its effectiveness in relieving primary dysmenorrhea, which is severe menstrual pain[6].

How It Works

Nomegestrol acetate works by mimicking the effects of progesterone, a natural hormone in the body. When combined with estradiol, it can:

  • Prevent ovulation (the release of an egg from the ovaries)
  • Thicken cervical mucus, making it harder for sperm to reach the egg
  • Thin the lining of the uterus, making it less likely for a fertilized egg to implant

In the context of multiple sclerosis, researchers believe that nomegestrol acetate and estradiol may help modulate the immune system and potentially promote remyelination (repair of damaged nerve coatings)[5].

Administration Methods

Nomegestrol acetate can be administered in several ways:

  • Oral tablets: It is commonly available as a pill taken by mouth. For example, one formulation contains 2.5 mg of nomegestrol acetate and 1.5 mg of estradiol[1].
  • Vaginal rings: Some studies are investigating the use of vaginal rings that release nomegestrol acetate and estradiol over time[6].

Effectiveness

The effectiveness of nomegestrol acetate depends on its specific use:

  • As a contraceptive: When used correctly, it is highly effective in preventing pregnancy. Studies are ongoing to determine its exact efficacy rate[3].
  • For endometrial preparation: Research is being conducted to assess its effectiveness in preparing the uterine lining for procedures like hysteroscopic polypectomy (removal of uterine polyps)[4].
  • For dysmenorrhea: Studies are investigating its potential to relieve menstrual pain and reduce the need for pain medication[6].

Side Effects and Safety

Like all medications, nomegestrol acetate can cause side effects. Common side effects may include:

  • Changes in menstrual bleeding patterns
  • Headache
  • Nausea
  • Breast tenderness

Some studies are specifically looking at the safety profile of nomegestrol acetate, including its effects on blood clotting[2]. It’s important to discuss potential risks and side effects with your healthcare provider before starting this medication.

Ongoing Research

Several clinical trials are currently underway to further investigate the uses and effects of nomegestrol acetate:

  • Its potential in preventing multiple sclerosis relapses after childbirth[5]
  • Its effectiveness in relieving menstrual pain when administered via vaginal rings[6]
  • Its use in preparing the uterine lining for certain gynecological procedures[4]
  • Comparisons of its effects on blood clotting with other contraceptive medications[2]

These ongoing studies aim to provide more information about the safety, efficacy, and potential new uses of nomegestrol acetate in various medical conditions.

Aspect Details
Formulations Studied Oral pills, vaginal rings
Combinations Nomegestrol Acetate with Estradiol in various doses
Key Study Objectives Contraceptive efficacy, ovulation inhibition, bleeding patterns, effects on dysmenorrhea
Comparisons Other progestins (e.g., etonogestrel), placebo
Safety Assessments Blood clotting factors, adverse events, bleeding patterns
Potential Benefits Effective contraception, improved dysmenorrhea symptoms, favorable safety profile
Additional Applications Endometrial preparation for procedures like hysteroscopic polypectomy

FAQ

  • What is Nomegestrol Acetate? Nomegestrol Acetate is a progestin hormone being studied for use in contraceptives. It is often combined with estradiol to create new birth control formulations.
  • What forms of contraceptives with Nomegestrol Acetate are being studied? Clinical trials are investigating Nomegestrol Acetate in oral pills and vaginal rings. Some studies are looking at combinations with estradiol in different doses.
  • What are some potential benefits of contraceptives containing Nomegestrol Acetate? Researchers are studying if Nomegestrol Acetate contraceptives can provide effective birth control while potentially improving issues like dysmenorrhea (painful periods) and offering a good safety profile.
  • How does Nomegestrol Acetate compare to other progestins used in birth control? Some trials are comparing Nomegestrol Acetate to other progestins like etonogestrel. Researchers are evaluating factors like ovulation inhibition, bleeding patterns, and effects on blood clotting.
  • Are there any risks or side effects associated with Nomegestrol Acetate contraceptives? As with any medication, there may be potential side effects. The clinical trials are carefully monitoring safety, including effects on blood clotting, bleeding patterns, and other adverse events. More research is needed to fully understand the risk profile.

Ongoing Clinical Trials on Nomegestrol Acetate

  • Study on the Effects of Vaginal Estrogen Treatment with Nomegestrol Acetate and Estradiol Hemihydrate on Blood Clotting in Postmenopausal Women with Vaginal Atrophy

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark

  • Study on Infertility: Effects of Choriogonadotropin Alfa, Nomegestrol Acetate, Estradiol Hemihydrate, and Progesterone in Patients Undergoing Frozen Embryo Transfer

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Spain

Glossary

  • Nomegestrol Acetate: A progestin hormone being studied for use in contraceptives, often combined with estradiol.
  • Estradiol: A form of estrogen hormone often combined with progestins in contraceptives.
  • Progestin: A synthetic form of progesterone, a female sex hormone used in birth control.
  • Dysmenorrhea: Painful menstrual cramps and associated symptoms during menstruation.
  • Ovulation: The release of an egg from the ovary during the menstrual cycle.
  • Breakthrough bleeding: Unexpected vaginal bleeding that occurs between menstrual periods while using hormonal contraceptives.
  • Pharmacokinetics: The study of how a drug is absorbed, distributed, metabolized, and eliminated by the body.
  • Bioequivalence: When two medications have the same active ingredient and produce the same effect in the body.
  • Endometrial preparation: The process of preparing the lining of the uterus, often for medical procedures.
  • Hysteroscopic polypectomy: A minimally invasive procedure to remove polyps from the uterus using a hysteroscope.

References

  1. https://clinicaltrials.gov/study/NCT00711607
  2. https://clinicaltrials.gov/study/NCT03531437
  3. https://clinicaltrials.gov/study/NCT01723579
  4. https://clinicaltrials.gov/study/NCT06316219
  5. https://clinicaltrials.gov/study/NCT00127075
  6. https://clinicaltrials.gov/study/NCT01670656